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Antibacterial Activities of Rhodamine B-Conjugated Gelsolin-Derived
Peptides Compared to Those of the Antimicrobial Peptides Cathelicidin
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Abstract
The growing number of antibiotic-resistant bacteria necessitates the search for new antimicrobial agents and
the principles by which they work. We report that cell membrane-permeant rhodamine B (RhB)-conjugated
peptides based on the phosphatidylinositol-4,5-bisphosphate binding site of gelsolin can kill the gram-
negative organisms Escherichia coli and Pseudomonas aeruginosa and the gram-positive organism Streptococcus
pneumoniae. RhB linkage to the QRLFQVKGRR sequence in gelsolin was essential for the antibacterial
function, since the unconjugated peptide had no effect on the bacteria tested. Because RhB-QRLFQVKGRR
(also termed PBP10), its scrambled sequence (RhB-FRVKLKQGQR), and PBP10 synthesized from D-
isomer amino acids show similar antibacterial properties, the physical and chemical properties of these
derivatives appear to be more important than specific peptide folding for their antibacterial functions. The
similar activities of PBP10 and all-D-amino-acid PBP10 also indicate that a specific interaction between RhB
derivatives and bacterial proteins is unlikely to be involved in the bacterial killing function of PBP10. By using
a phospholipid monolayer system, we found a positive correlation between the antibacterial function of
PBP10, as well as some naturally occurring antibacterial peptides, and the intrinsic surface pressure activity at
the hydrophobic-hydrophilic interface. Surprisingly, we observed little or no dependence of the insertion of
these peptides into lipid monolayers on the phospholipid composition. These studies show that an effective
antimicrobial agent can be produced from a peptide sequence with specificity to a phospholipid not found in
bacteria, and comparisons with other antimicrobial agents suggest that the surface activities of these peptides
are more important than specific binding to bacterial proteins or lipids for their antimicrobial functions.
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The growing number of antibiotic-resistant bacteria necessitates the search for new antimicrobial agents and
the principles by which they work. We report that cell membrane-permeant rhodamine B (RhB)-conjugated
peptides based on the phosphatidylinositol-4,5-bisphosphate binding site of gelsolin can kill the gram-negative
organisms Escherichia coli and Pseudomonas aeruginosa and the gram-positive organism Streptococcus pneu-
moniae. RhB linkage to the QRLFQVKGRR sequence in gelsolin was essential for the antibacterial function,
since the unconjugated peptide had no effect on the bacteria tested. Because RhB-QRLFQVKGRR (also termed
PBP10), its scrambled sequence (RhB-FRVKLKQGQR), and PBP10 synthesized from D-isomer amino acids
show similar antibacterial properties, the physical and chemical properties of these derivatives appear to be
more important than specific peptide folding for their antibacterial functions. The similar activities of PBP10
and all-D-amino-acid PBP10 also indicate that a specific interaction between RhB derivatives and bacterial
proteins is unlikely to be involved in the bacterial killing function of PBP10. By using a phospholipid monolayer
system, we found a positive correlation between the antibacterial function of PBP10, as well as some naturally
occurring antibacterial peptides, and the intrinsic surface pressure activity at the hydrophobic-hydrophilic
interface. Surprisingly, we observed little or no dependence of the insertion of these peptides into lipid
monolayers on the phospholipid composition. These studies show that an effective antimicrobial agent can be
produced from a peptide sequence with specificity to a phospholipid not found in bacteria, and comparisons
with other antimicrobial agents suggest that the surface activities of these peptides are more important than
specific binding to bacterial proteins or lipids for their antimicrobial functions.
Antimicrobial peptides are nonadaptive host defense mole-
cules that provide a first line of defense against a wide spec-
trum of pathogens. They are found in all species ranging from
protozoa to vertebrates. In mammals, these peptides are stored
in granules of leukocytes and are present on mucosal surfaces
and skin (31). In the last decade, they have become an impor-
tant focus of study due to their possible applications as a new
source of antibiotics, anticancer drugs, food preservatives, and
antiseptic agents (32). It has been proposed that a variety of
antimicrobial peptides kill bacteria by interacting with the an-
ionic phospholipid of the bacterial inner membrane or with the
hydrophilic lipopolysaccharide (LPS) of the cell wall of gram-
negative bacteria. As a result of this relatively nonspecific in-
teraction, insertion of antibacterial peptides in the bacterial
membrane occurs, resulting in either its permeabilization or
disruption. This leads to changes in secondary messenger sys-
tems that further augment the abnormal electrical activity and
that disrupt signal transduction, causing bacterial death (14).
However, understanding of the peptide-mediated bacterial
killing mechanism(s) is still incomplete. The proline- and argi-
nine-rich bactenecin (Bac) peptides (Bac5 and Bac7, respec-
tively) from bovine neutrophil granules inhibit incorporation
of precursor molecules into Escherichia coli protein and RNA
(27), and cecropin (PR-39) from pig small intestine has been
shown to prevent protein and DNA synthesis in gram-negative
bacteria (3). Antimicrobial peptides might also act through
mechanisms other than bacterial membrane destabilization or
nucleic acid and protein synthesis inhibition. Recently, recep-
tor-mediated stimulation of host defense mechanisms by some
antibacterial peptides has been established (7). The antimicro-
bial peptides magainin II, indolicidin, and temporins (B and L)
were found to modulate the hydrolytic activity of secretory
phospholipase A2 from bee venom and human lacrimal fluid
(36).
Coupling between the innate and adaptive immune systems
is likely, and antimicrobial peptides appear to influence both
the quality and the effectiveness of the immune responses (31,
36). Rabbit cathelicidin-derived CAP18 and human cathelici-
din-derived CAP18 (peptide LL37) inhibit the biological activ-
ity of LPS and reduce the lethality of LPS in murine models of
endotoxemia (15, 16), whereas PR-39 can induce expression of
cell surface heparan sulfate proteoglycans (syndecan-1 and -4)
as part of the wound repair process (11, 33).
* Corresponding author. Mailing address: Department of Physiol-
ogy, University of Pennsylvania, IME, 3340 Smith Walk, Philadelphia,
PA 19104. Phone: (215) 573-9787. Fax: (215) 573-7227. E-mail:
buckirob@mail.med.upenn.edu.
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The relationship between the bactericidal activities and the
physicochemical properties of antibacterial peptides has been
intensively studied. Peptide activities correlated positively with
the gradient of hydrophobicity along the peptide backbone,
with a net positive charge at neutral pH and with -helical
structures (13, 34). There is, however, no sequence homology
among families of antimicrobial peptides.
The PBP10 peptide, whose sequence is derived from the
phosphoinositide (PPI)-binding region in gelsolin, bears some
resemblance to the antibiotic peptides, such as a short se-
quence with a net positive charge and membrane permeation.
Additionally, circular dichroism and nuclear magnetic reso-
nance imaging studies show that peptides based on gelsolin
residues 150 to 169 undergo a coil-to-helix transition in the
presence of phosphatidylinositol-4,5-bisphosphate (PIP2) and
other acidic surfactants (30). This helical structure produces an
amphipathic molecule with positive charges arranged on one
face and hydrophobic residues arranged on the other. Unique
properties of PBP10 include PPI binding due to the cationic
amino acid composition and hydrophobicity due in part to the
linked fluorophore. These traits allow PBP10 to enter cells
passively and to affect many cellular functions dependent on
PPI signaling, including cell motility (6), platelet activation (5),
and canalicular membrane ATP-dependent vesicle transport
(24).
In this study we characterized the bacterial killing properties
of peptides based on the PIP2-binding site of gelsolin and
compared them with the antibacterial functions of cathelicidin
LL37, magainin II, and melittin. We found a positive correla-
tion between the antibacterial functions of those agents and
their surface pressure activities.
MATERIALS AND METHODS
Materials. Magainin II (catalog no. M-7402), synthetic melittin (catalog no.
M-4171), L--phosphatidylcholine (catalog no. P-6638), L--phosphatidyl-L-
serine (catalog no. P-6641), cholesterol (catalog no. C-8667), L--phosphatidyl-
glycerol dipalmitoyl (catalog no. P-9789), and cardiolipin (catalog no. C-1649)
were obtained from Sigma. Brain PIP2, tri-ammonium salt (catalog no. 840046),
was from Avanti Polar Lipids. Tryptic soy broth (catalog no. 0370-17-3), Pseudo-
monas isolation agar (catalog no. 0927-17-1), and blood-based agar (catalog no.
0045-17) were from Difco. Peptide LL37 was synthesized with an automatic
peptide synthesizer monitored by mass spectrometry and capillary electrophore-
sis at the Louisiana State University Medical Center Core Laboratories. The set
of gelsolin-related peptides, including QRL, QRLFQV, QRLFQVKGRR (GS
160-169), all-D-amino-acid QRLFQVKGRR (all-D-QRLFQVKGRR), FRV
KLKQGQR, and KHVVPNEVVVQRLFQVKGRR (GS 150-169), were pre-
pared in the Peptide Synthesis Laboratory (Riga, Republic of Latvia) either as
free peptides or as peptides conjugated to rhodamine B (RhB) with an amide
link at the N terminus of the peptide (denoted with RhB as a prefix to the
peptide sequence), as described previously (6).
Antimicrobial activities. The bactericidal activities of the different antibacte-
rial peptides were measured as described previously (26); kanamycin-resistant E.
coli (SG 13009), kanamycin-resistant Pseudomonas aeruginosa (PAO1), and
Streptococcus pneumoniae (STG) were grown to mid-log phase at 37°C, resus-
pended in phosphate-buffered saline (PBS; 140 mM NaCl, 7.5 mM Na2HPO4
[pH 7.4]), and brought to 108 CFU/ml (with the assumption that an optical
density at 620 nm of 0.35 corresponds to 108 CFU/ml). They were then diluted
10 times in 100 l of PBS containing different antibacterial and control peptides.
After 1 h of incubation at 37°C, the suspensions were placed on ice and diluted
10- to 10,000-fold in PBS, and 10-l aliquots were spotted on Lura-Bertani agar
plates, Pseudomonas isolation agar plates, or blood-based agar plates (for E. coli,
PAO1, and STG, respectively) for overnight culture at 37°C. Manual counting of
the numbers of CFU was performed.
Examination of bacterial morphological changes by electron microscopy.
Samples containing E. coli (108 CFU/ml) in 140 mM NaCl–10 mM Na2HPO4
(pH 7.4) were incubated for 45 min with 5 to 10 M PBP10, 10 M RhB-QRL,
or 5 M peptide LL37. After centrifugation at 3,000  g for 5 min, a drop of the
bacterial suspension was deposited onto a grid and negatively stained with 0.25%
phosphotungstic acid (PTA). The grids were examined with a JEOL JEM-1010
electron microscope.
Surface pressure and incorporation of the peptides into lipid monolayers. The
surface activities of the peptides were measured with a Trough S instrument
(Kibron Inc., Helsinki, Finland), as described elsewhere (20). PBS (1 ml) was
placed in each of the 15 wells in a multiple-well trough, and the surface pressure
() was measured for 30 min after injection of the desired volume of the peptide
stock solution below the monolayer-covered surface. Kinetic measurements of
the  values showed stable readings after 5 min, and the  values remained
constant (within 5%) for at least 45 min for all pressures reported. The lipid
monolayers residing on the air-water interface provided a convenient means to
assess the lipophilicities of the peptides by monitoring the increase in  caused
by peptide insertion into the lipid film (4). To investigate the interaction of
peptide LL37 and the RhB-QRLFQVKGRR peptide with lipid monolayers,
various amounts of different phospholipids from a chloroform stock solution
were spread at the liquid-air interface to give an initial  (0). Thirty minutes
after monolayer formation (0), the desired volume of peptide stock solution was
injected below the monolayer-covered surface through an injection septum, and
the subphase was stirred for 30 s. The change in  () from 0 after the
addition of peptide was complete in approximately 30 min, and the difference
between 0 and the value observed after equilibration of the surface with the
peptide solution was taken as . The data are represented as  versus 0 (4).
All of the measurements were performed at room temperature.
Lipid extractions and analysis. Extraction of lipids from the bacteria was
performed by the methods described by Rozgonyi et al. (23). The bacterial
culture was washed with ice-cold buffer A (140 mM NaCl, 10 mM Tris [pH 5])
and centrifuged; the pellet was extracted in 5% trichloroacetic acid for 15 min to
remove nonlipid materials that can be dissolved in lipid solvent. The extraction
of lipids from the bacterial mass was performed in a mixture of chloroform-
methanol-HCl at relative concentrations of 20:40:1 (by volume) for 2 h at room
temperature. Separation of the organic phase was performed by adding water to
this system. After the lipids were extracted, they were separated into different
fractions by thin-layer chromatography with silica plates (0.25 mm; Merck) de-
veloped with chloroform-methanol-acetic acid-H2O (77:49:10:6, by volume) for
phospholipid analysis (35).
RESULTS
Bactericidal activity. By using a standard killing assay for E.
coli, we compared the antimicrobial activities of the naturally
occurring antibacterial agents mellitin, magainin II, and pep-
tide LL37 (Table 1) with those of synthetic RhB-labeled de-
rivatives of the PIP2-binding site of gelsolin (Fig. 1A and B).
Additionally, we tested the ability of RhB-labeled peptides to
kill other bacterial strains, including the gram-negative species
TABLE 1. Sequences of selected antibacterial peptides
Peptide Sequence Source
LL37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES Human cathelicidin (hCAP18)
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ Honeybee (Apis mellifera) venom
Magainin II GIGLFLHSALLFGLAFVGGIMNS Frog (Xenopus laevis) skin
PBP10 RhB-QRLFQVKGRR PIP2-binding site of gelsolin
(positions 150–169)
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P. aeruginosa and the gram-positive species S. pneumoniae (Fig.
1C and D). As determined by in vitro assays, the antibacterial
concentrations of naturally occurring antimicrobial peptides var-
ied from 1 to 100 M. PBP10 and its derivatives, RhB–all-D-
QRLFQVKGRR and RhB-FRVKLKQGQR, quickly and effi-
ciently killed nearly all E. coli organisms at concentrations of 5 to
15 M (Fig. 1). This antibacterial activity is similar to that of
magainin II but is 10 times less than those of mellitin and peptide
LL37, which at concentrations of 1 M and 0.5 to 1 M, respec-
tively, kill approximately 100% of E. coli isolates. Under the same
conditions, the number of growing colonies was not affected by
RhB, RhB-QRL, GS 150-169, GS 160-169, or full-length gelsolin
(data not shown), indicating the importance of the RhB link to
the peptide sequences for the antibacterial actions of these
agents. The GS 150-169 peptide, which has physical properties
similar to those of the active -helical peptides, had no antibac-
terial activity, possibly because it lacked the tryptophan residue
required for insertion of the peptide into the lipid membrane
(10). The RhB-QRLFQV peptide was the shortest peptide with
antibacterial activity and killed nearly 100% of the E. coli organ-
isms at a concentration of 50 M. PBP10 also killed bacteria of
the genera Pseudomonas and Streptococcus, but at higher concen-
trations compared to that necessary to kill E. coli.
The morphological changes of the bacteria after treatments
with PBP10 and peptide LL37 are shown in Fig. 2. PBP10 at a
concentration of 5 M, which killed 80% of the E. coli
organisms, caused an increase in bacterial membrane perme-
ability on the basis of the intensity of PTA staining. This result
suggests that PBP10 mainly targets the bacterial membrane.
An increase in the PBP10 concentration (to 10 M) resulted in
the irregular disruption of the bacterial membrane and wall.
Round PTA-stained remnants of completely lysed bacteria
after PBP10 and LL37 treatments are shown in Fig. 2C1 and
D1, respectively.
Surface activities of antibacterial peptides. One of the com-
mon characteristics of antibacterial peptides is their ability to
destabilize the bacterial membrane and increase its permeabil-
ity. To determine whether the membrane permeation activities
of those agents correlate with their amphipathic character,
which promotes partitioning to the hydrophobic interface, the
 values at the air-water interface were measured in the pres-
ence of various concentrations of the RhB-linked peptides
FIG. 1. Viabilities of E. coli (A and B), P. aeruginosa (C), and S. pneumoniae (D) after 1 h of incubation with various concentrations of
antibacterial peptides. Each datum point represents the mean of three to five experiments. The effects of the peptides were calculated by taking
the number of CFU in the sample with no drug treatment (growth control) as 100%. The standard deviation is less than 15% and for the sake of
clarity is not shown.
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mellitin, magainin II, and peptide LL37. Figure 3 shows how 
changes when increasing amounts of antibacterial peptides are
added to PBS solutions. A significant increase in  occurred at
RhB-linked peptide concentrations between 0.5 and 10 M.
The surface activities of the naturally occurring antibacterial
peptides were approximately 10 times stronger than those of
the RhB derivatives. The surface activities of RhB-labeled and
unlabeled peptide QRLFQVKGRR are much weaker than
those of the RhB conjugates.
Bactericidal and  activities of antibacterial peptides. As
shown in Fig. 3, the antibacterial peptides exhibited different 
activities, and there appears to be a relationship between 
activity and bacterial killing efficiency. To investigate more
quantitatively the relation between partitioning to hydrophobic
interfaces and the killing activities of antibacterial peptides, we
conducted a standard bacterial killing assay with E. coli using
concentrations of the various peptides just sufficient to pro-
duce  values at the air-water interface of 20 0.5 mN/m (0.11
M LL37, 0.12 M melittin, 0.15 M magainin II, 1.1 M
RhB-FRVKLKQGQR, 1.4 M RhB-QRLFQVKGRR or
RhB–all-D-QRLFQVKGRR, and 12 M RhB-QRLFQV).
Figure 4 shows that these concentrations of the structurally
distinct peptides killed 60%  15% of the E. coli organisms,
indicating a positive correlation between  and the killing
activities of these antibacterial agents.
Insertion of LL37 and PBP10 peptides into lipid monolay-
ers. Partitioning to the air-water interface is expected for any
amphipathic solute; but partitioning of amphipathic peptides
to the membrane can depend on the lipid packing density, the
structure of the peptide, the distribution of surface charges,
and other features that mediate the balance between surface
adsorption and incorporation into the hydrophobic layer of the
membrane. The intercalation of antimicrobial peptides into
lipid monolayers compressed at the air-water interface to dif-
ferent 0 values was observed by measuring  following the
addition of the PBP10 or the LL37 peptide into the aqueous
subphase (37). As shown in Fig. 4A, insertion of LL37 peptides
(0.1 M) into various phospholipid monolayers composed of
phosphatidylcholine (PC), 1,2-dimyristoyl-glycero-3-phospho-
choline (DMPC), PC-cholesterol (CH), PC-phosphatidylserine
(PS), PC-PIP2, PC–L--phosphatidylglycerol dipalmitoyl
(DPPG), PC-cardiolipin (CL), and total lipid extract from E.
coli (bacterial lipids [BLs]) did not result in any significant
differences in  values. The phospholipid composition of BL
was as follows: PS, 2.94%  0.57%; phosphatidylethano-
lamine, 77%  1.3%; CL, 12%  1.41%; and other phospho-
lipids (including phosphatidylglycerol), 12.1%  1.2%. The
observation of a lack of significant differences in  values
suggests that the phospholipid composition of the outer leaflet
of bacterial membranes with high concentrations of negatively
charged phospholipids, which are not found in mammalian
cells, is not the only factor determining the high degree of
FIG. 2. Electron micrographs of negatively stained E. coli un-
treated (A and A1) and treated with antibacterial peptides: 5 M
PBP10 (B and B1), 10 M PBP10 (C and C1), and 5 M LL37 peptide
(D and D1). The images shown were obtained in a single experiment.
Two other experiments gave similar images. Bars, 500 nm.
FIG. 3. (A)  values at the liquid-air interface for PBS with differ-
ent concentrations of peptides. Each datum point represents the mean
of five to six experiments. The standard deviation is less than 1 mN/m
and for the sake of clarity is not shown. (B) Viability of E. coli after 1 h
of incubation with different antibacterial peptides at concentrations at
which  was 20  0.5 mN/m. The data shown are the means 
standard deviations of three experiments.
VOL. 48, 2004 ANTIBACTERIAL ACTIVITY OF PBP10 1529
 at UNIVERSITY O











toxicity of the LL37 peptide against E. coli cells but a negligible
effect on platelets or red blood cells (data not shown). How-
ever, the lack of LL37 insertion into the positively charged
1,2-dioleoyl-3-trimethylammonium propane monolayer (Fig.
4A) shows the importance of charge interactions during inser-
tion of antibacterial peptides into the cell membrane. A similar
experiment with 0.1 M PBP10 (Fig. 4B) shows a smaller
increase in  values (less than 10-mN/m increases even at low
0 values). At higher values of 0, the addition of PBP10
causes a small decrease in , but as expected for a peptide
based on a specific lipid-binding domain, there is a significant
dependence on the lipid composition.
Since the antibacterial activity of the LL37 peptide is
strongly dependent on its -helicity, which can be modulated
by changing the ion composition and the pH of the buffer (13),
we designed an experiment in which the same amount of PC or
BL was spread on the surfaces (0 	 20  0.5 mN/m) of
hypotonic (pH 7.4) or isotonic (pH 3.0 to 9.0) buffers. As
shown in Fig. 5A, insertion of the LL37 peptide (0.1 M) into
the PC and BL monolayer occurred only when the phospho-
lipids were spread on isotonic solutions. Insertion of LL37
peptides into PC as well as BL monolayers was also modulated
by the H concentration, with a maximal effect at pH 7.4.
Insertion of PBP10 into PC monolayers was also stronger in
isotonic buffers at physiological pH than in acidic or basic
environments (Fig. 5B), suggesting either pH-dependent con-
formational changes in PBP10 or, possibly, changes in the
degree of ionization or conformation in the lipid. This result
confirms previous observations that showed a strong depen-
dence of PBP10 fluorescence on the H concentration (6). The
interactions of PBP10 with BL monolayers spread on isotonic
or hypotonic medium at pH 7.4 were not significantly different.
Interestingly, a decrease in  was observed during the inter-
action of the PBP10 peptide with BL phospholipids spread on
the buffer when the pH was 
5 or 9.
DISCUSSION
Defining the structure-function relationships for antimicro-
bial peptides would have many implications for the design of
new therapeutic agents that could be used to counter infections
and avoid antibiotic resistance. Nearly all antimicrobial pep-
tides are cationic amphiphiles; but a common mechanism that
accounts for their selective destruction of bacterial membranes
FIG. 4. Interaction of LL37 (A) and PBP10 (B) peptides (both at a
concentration of 0.1 M) with lipid monolayers obtained by spreading
chloroform solutions of different lipids on the liquid-air interface. The
data shown on panels A and B were obtained in a single experiment.
Two other experiments gave similar data. DOTAP, positively charged
1,2-dioleoyl-3-trimethylammonium propane.
FIG. 5. Effect of pH and ionic strength on LL37 (A) and PBP10
(RhB-QRLFQVKGRR) (B) interaction with PC monolayers spread
on isotonic (circles with points) and hypotonic (empty squares) buffer
or BL monolayers spread on isotonic (filled circles) and hypotonic
(filled triangles) buffers. The 0 value for all PC and BL monolayers
was 20  0.5 mN/m. Data shown represent  (  0) and are the
means  standard deviations of four to five experiments.
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while leaving eukaryotic membranes intact has not been re-
vealed, and different antimicrobial peptides may function by
distinct mechanisms. The present work contributes two results
that may have implications for the function of antimicrobial
peptides. An effective antimicrobial agent was produced from
a peptide sequence with no relation to any natural antibiotic
function. Antibacterial RhB conjugates are derived from the
gelsolin binding site for PPIs, a class of lipids not present in the
vast majority of known bacteria, and the PPI-binding sequence
bears little homology to the sequences of antimicrobial pep-
tides, aside from its basic and hydrophobic character. When
the bactericidal activities of structurally distinct peptides at
different concentrations are compared, there appears to be a
relationship between their bactericidal efficiencies and their
surface activities at the air-water interface.
The structures and amino acid compositions of natural an-
tibacterial peptides have been modified experimentally to pro-
duce improved antibacterial and antifungal agents with high
levels of antibiotic activity but low levels of hemolytic activity.
In part, this goal is attainable by increasing the net positive
charge by lysine substitution (25), increasing the net hydropho-
bicity by tryptophan substitution (17, 18), conjugation of pep-
tides with lipophilic acid (1), incorporation of a carbamate
bond(s) (19), synthesis of hybrid peptides (22), and synthesis of
truncated sequences that omit hemolytic regions (29). The
results presented here show that linkage of the hydrophobic
molecule RhB to the QRLFQVKGRR, all-D-QRLFQVKG
RR, and FRVKLKQGQR sequences based on the PIP2-bind-
ing site of gelsolin (1) also produced new antimicrobial agents.
PBP10 has antibacterial activity against gram-negative
and gram-positive bacteria, while free RhB, nonlabeled
QRLFQVKGRR and KHVVPNEVVVQRLFQVKGRR
peptides, and gelsolin lack the ability to kill bacteria. By
linking RhB to the GS 160-169 sequence, the net hydropho-
bicity of this molecule increases, and this effect may increase
its membrane permeation function (Fig. 6). Some cellular
processes associated with PPI metabolism are effectively
modulated by PBP10 (5, 6, 12, 24), but not by the scrambled
form of PBP10, in which changes in the amino acid sequence
disrupt its PPI-binding ability (6, 12). Because the scram-
bled form of PBP10 kills bacteria over the same concentra-
tion range as the original peptide, the net positive charge of
RhB-labeled peptides appears to be more important than
their specific structure or their ability to bind to PPI for the
antibacterial functions of the peptides. PBP10 synthesized
from the D-isomer forms of the amino acids also had anti-
bacterial properties similar to those of PBP10 synthesized
from the L-isomer forms. This observation rules out the
FIG. 6. Edmundson helical wheel plots for LL37 (A), magainin II (B), mellitin (C), and PBP10 (D) peptides. Lines divide the helix into
hydrophobic (shaded residues) and hydrophilic parts. An amphipathic helical structural prediction has been confirmed by circular dichroism
spectroscopy for most of these peptides (34). On the basis of the circular dichroism of GS 150-169 (30), we assumed that PBP10 can also adopt
a helical conformation.
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involvement of a specific PBP10-bacterial protein interac-
tion and agrees with recent observations showing that the
natural and synthetic (all-D-isomer-form) forms of cecropin
have comparable antibacterial activities (2).
The membrane permeation function of antibacterial pep-
tides is associated with an amphipathic character that pro-
motes partitioning to the hydrophobic interface. Measurement
of the intrinsic surface activities of the PBP10, melittin, ma-
gainin II, and LL37 peptides reveals a positive correlation
between their  activities and their antibacterial functions.
Molecule hydrophobicity does not ensure binding of the mol-
ecule to different phospholipids (21), but it favors penetration
of the molecule into phospholipid monolayers. In effect, hy-
drophobic forces seem to govern the interaction of antimicro-
bials with lipid membranes. We propose that simple measure-
ments of intrinsic  activity can be used to estimate the
concentrations of antibacterial agents required for their mem-
brane-destabilizing insertion.
The interaction between the peptides absorbing into the
lipid monolayer and the individual molecules composing this
surface is determined by a number of factors (8, 28). No sig-
nificant head-group dependency was observed for the interac-
tion of LL37 with monolayers of PC, DMPC, PC-CH, PC-PS,
PC-PIP2, PC-DPPG, PC-CL, and a mixture of BLs, suggesting
little or no specificity of the LL37 peptide for the polar head
groups of the lipids under the test conditions used in our
experiments. This observation suggests that a negative charge,
even in the context of a zwitterionic lipid, and its density on the
bacterial surface could be more important than the specific
type of phospholipid present in the bacterial membrane.
When PBP10 (0.1 M) was injected under a monolayer
containing negatively charged phospholipids, especially PC-
PIP2, a decrease in  (below 0) was observed. This result
suggests that during the interaction of PBP10 with lipid mono-
layers, anionic phospholipids attracted by the positively
charged PBP10 peptide reorganized their packing to reduce .
Previous microscopy observations have demonstrated that ad-
dition of fluorescein-labeled peptide QRLFQVKGRR to the
aqueous subphase of a PC-, PIP-, Texas Red-, and phosphati-
dylethanolamine-containing monolayer caused segregation of
highly charged phospholipids into domains (9). A similar for-
mation of lipid domains may precede or accompany the cell
membrane reorganization that eventually leads to permeabili-
zation or rupture. Whether the induction of lipid domains is a
general property of antimicrobial peptides has not been inves-
tigated, but the data presented here suggest that nonspecific
surface activity independent of or in addition to the presence
of specific binding sites for antimicrobial peptides may be an
important determinant of their biological function.
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